Opioid poorly-responsive cancer pain. Part 3. Clinical strategies to improve opioid responsiveness

Journal of Pain and Symptom Management
Sebastiano Mercadante, R K Portenoy

Abstract

Some pain syndromes may be difficult to treat due to a poor response to opioids. This situation demands a range of alternative measures, including the use of adjuvant drugs with independent effects, such as antidepressants, sodium channel-blocking agents, steroids and anti-inflammatory drugs (NSAIDs); drugs that reduce opioid side effects; and drugs that enhance analgesia produced by opioids, such as N-methyl-D-aspartate (NMDA) antagonists, calcium channel antagonists, and clonidine. Other approaches, including opioid trials, neural blockade when necessary, and psychological interventions, also may be useful.

References

Mar 31, 1977·The New England Journal of Medicine·W H ForrestG Teutsch
Nov 1, 1992·Journal of Pain and Symptom Management·A J RichtsmeierM Alexander
Oct 24, 1992·Lancet·J S MorleyD Bowsher
Aug 1, 1992·Pain·Sebastiano MercadanteLeonardo Salvaggio
May 1, 1992·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·J L Bem, R Peck
Aug 1, 1992·Anaesthesia·H J McQuayC J Glynn
Mar 1, 1992·Pain·P MarchettiniS Smirne
Apr 1, 1992·Pain·Richard D PennJeffrey S Kroin
Jul 1, 1992·Anesthesiology·M F Watcha, P F White
Jan 1, 1991·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A T van Holten-VerzantvoortF J Cleton
Jun 1, 1990·Pain·R K Portenoy, N A Hagen
Apr 1, 1991·Pain·S Mercadante
May 1, 1991·Pain·William G Brose, Micheal J Cousins
Jan 1, 1991·Journal of Pain and Symptom Management·S Glazer, R K Portenoy
Oct 1, 1990·Journal of Pain and Symptom Management·R K Portenoy, N Coyle
Apr 1, 1990·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·E OshimaN Urabe
Jun 1, 1988·International Journal of Dermatology·R J Hawk, L E Millikan
Jun 1, 1988·Pain·Peter N C WatsonVerna R Watt
Jul 15, 1989·BMJ : British Medical Journal·J M PotterP E Hickman
Sep 9, 1989·BMJ : British Medical Journal
Nov 1, 1989·Pain·Ch J Vecht
Mar 1, 1989·Pain·David E Weissman, David J Haddox
Jul 1, 1989·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·P LatiniE Perrucci
Apr 1, 1988·Acta Anaesthesiologica Scandinavica·A Vainio, I Tigerstedt
May 1, 1988·Pain·J A Dalton, M Feuerstein
Jun 1, 1987·Journal of Clinical Psychopharmacology·F FernandezV F Holmes

❮ Previous
Next ❯

Citations

Oct 29, 2002·Annals of Neurology·James R GossDavid J Fink
Aug 10, 2007·Current Pain and Headache Reports·Paul A Sloan
Feb 22, 2003·Journal of the American College of Surgeons·A Reed Thompson, James B Ray
Aug 15, 2002·BJU International·F Heid, J Jage
May 25, 2002·Cancer Practice·Lise K Lucas, Arthur G Lipman
Aug 16, 2011·Journal of Palliative Medicine·Christopher KerrRobert Milch
Apr 6, 2013·Journal of Palliative Medicine·Shelley R SalpeterEduardo Bruera
Oct 5, 2006·Current Opinion in Anaesthesiology·H Smith, J Elliott
Jun 25, 2008·The Clinical Journal of Pain·Juan-Diego Harris
Jan 26, 2016·Critical Reviews in Oncology/hematology·Sebastiano Mercadante, Eduardo Bruera
Nov 6, 2004·Cancer·Miguel Angel Benítez-RosarioJosé Javier Martín-Ortega
Sep 1, 2005·The Lancet Oncology·Mellar P DavisSusan B LeGrand
Jun 30, 2006·European Journal of Pain : EJP·Brian L SchmidtRichard C K Jordan
Sep 24, 2015·The International Journal of Neuropsychopharmacology·Luca PosaNicolas Marie
Jun 20, 2014·Journal of Pain and Symptom Management·Bruno GagnonPeter G Lawlor
Feb 8, 2008·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Eufemia Jacob, Brigitta U Mueller
Apr 20, 2007·BJU International·Jeffrey S TurnerDavid I Quinn
Oct 3, 2003·Expert Opinion on Pharmacotherapy·Robert B RaffaAlbert I Wertheimer
Aug 1, 2002·BMC Palliative Care·Frank D FerrisLinda L Emanuel
Dec 11, 2014·Journal of Palliative Medicine·Shelley R SalpeterEduardo Bruera
Mar 11, 2011·Pain·David K Lam, Brian L Schmidt
Jun 4, 2016·Anesthesia and Analgesia·Eellan SivanesanKeith A Candiotti
Sep 19, 2006·Pharmacology, Biochemistry, and Behavior·Manzumeh-Shamsi MeymandiMina Mobasher
Feb 1, 2005·Pharmacology, Biochemistry, and Behavior·Theo F Meert, Hilde A Vermeirsch
May 7, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Russell K Portenoy, Ebtesam Ahmed
Jan 15, 2004·Anesthesiology Clinics of North America·Paul J Christo
Jul 12, 2017·Journal of Oncology Practice·Aaron J FrankeThomas J George
Jul 11, 2013·The American Journal of Hospice & Palliative Care·Di DengYunfeng Zhou
Sep 6, 2005·European Journal of Pain : EJP·H C Müller-BuschS Woskanjan
May 31, 2018·Annals of the American Thoracic Society·Kunal KaramchandaniAvery Tung
Oct 26, 2018·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·O CorliM Pizzuto
Oct 4, 2019·CNS Drugs·Sebastiano MercadanteAngela Santoni
Nov 28, 2019·MMW Fortschritte der Medizin·Carmen Roch, Birgitt von Oorschot
Jan 5, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Rose Anne Indelicato, Russell K Portenoy
Oct 23, 2019·Journal of Pain & Palliative Care Pharmacotherapy·Shiao-Yen KhooPrita Nambbiar
Nov 29, 2002·Anesthesia and Analgesia·Jan H VrankenMisa Dzoljic
Mar 10, 2004·British Journal of Community Nursing·David T CowanPeter Griffiths
Mar 2, 2021·Cancer Management and Research·Stefano De SantisUNKNOWN IOPS-MS Study Group
Oct 1, 2018·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M FallonUNKNOWN ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.